Cited by 8Gestational Diabetes Research and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Screening methods for gestational diabetes mellitus in Japan in 2018: a retrospective cohort study using a national surveillance questionnaire

Open access
Morikawa, Mamoru, Sugiyama, Takashi, Hiramatsu, Yuji, Sagawa, Norimasa·2022·Endocrine Journal

Abstract

This study aimed to investigate the relationship between gestational diabetes mellitus (GDM) screening methods and GDM incidences. In 2018, a national questionnaire was administered at 231 institutions (56.6%) of all 408 perinatal medical centers in Japan. Of 100,485 women, 2,982 (3.0%) were diagnosed with GDM during their first pregnancy period (FPP) and 7,289 (7.3%) were diagnosed with GDM during their middle pregnancy period (MPP). The proportion of women diagnosed with GDM during FPP and MPP using 95 mg/dL as the cutoff value (CV) for random plasma glucose (PG) at FPP (4.3% and 9.2%) was significantly higher than that of women diagnosed with GDM using 100 mg/dL as the CV for random PG (2.7% and 6.9%, p < 0.0001, respectively). Compared with women screened for GDM using "random PG and random PG," women who were screened for GDM using "random PG and 50-g glucose challenge test (GCT)" had a significantly higher incidence of GDM (6.6% versus 8.9%, p < 0.0001). Using random PG and 50-g GCT, the incidence of GDM among women diagnosed at MPP using a CV of 95 mg/dL at FPP was significantly higher than that of women diagnosed using a CV of 100 mg/dL (16.5% versus 7.8%: p < 0.0001). While, using "random PG and random PG," the incidences of GDM among women were similar between institutions using a CV of 100 mg/dL and those using a CV of 95 mg/dL at FPP (6.7% versus 6.9%: p = 0.3581). This study showed random PG as a first-step screening method in MPP may overlook women with GDM.

Integrity signals

Registry

Crossref · 10.1507/endocrj.ej22-0072

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Japan, women screened for GDM using random plasma glucose and a 50 g GCT had a significantly higher incidence of GDM (6.6% vs. 8.9%, p < 0.0001).

    “Moreover, women who were screened for GDM using random plasma glucose and a 50 g GCT had a significantly higher incidence of GDM (6.6% vs. 8.9%, p < 0.0001) [226].”
  • In Japan, in 2018, the percentage of women screened using 5.3 mmol/L as cut-off for random plasma glucose was significantly higher than those tested using 5.55 mmol/L (2.7% and 6.9%, p < 0.0001).

    “The percentage of women screened using 5.3 mmol/L (95 mg/dL) as the cut-off value for random plasma glucose was significantly higher in comparison to those who were tested using 5.55 mmol/L (100 mg/dL) as the cut-off value for random plasma glucose (2.7% and 6.9%, p < 0.0001).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morikawa, M., Sugiyama, T., Hiramatsu, Y., & Sagawa, N.
Affiliations
  • Kansai Medical University (JP)
  • Ehime University (JP)
  • Okayama City Hospital (JP)
  • Rakuwakai Otowa Hospital (JP)
Venue
Endocrine Journal
Published
2022
Volume
69
Issue
11
Pages
1313-1322
ISSN
  • 0918-8959 (ISSN-L)
  • 1348-4540
OpenAlex
W4283825865
Cited by
8
References
1
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2022: 1
FWCI
1.76
Type
journal article
Language
en
Open access
Locations
  • Endocrine Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
Manpei Suzuki Diabetes Foundation
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
gestational diabetes mellitus, GDM screening, random blood glucose, glucose challenge test, cut-off values, screening incidence, first pregnancy, Japan
MeSH terms
Blood Glucose, Female, Humans, Japan, Mass Screening, Pregnancy, Retrospective Studies, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review